Core Insights - The core viewpoint of the article emphasizes the significant advancements made by the company in its environmental, social, and governance (ESG) practices, particularly through innovation and green initiatives. Group 1: Innovation and R&D Investment - In 2024, the company increased its R&D investment to 398 million yuan, a 40% increase from 284 million yuan in 2023 [1][3] - The number of R&D personnel rose from 972 in 2023 to over 1200, accounting for more than 10% of the total workforce [3] - The company launched 55 new products in the past year, a 197% increase, covering three core areas: medical consumables, health care devices, and medical care [4] Group 2: Environmental Impact and Green Initiatives - The carbon emissions per glove decreased to 20.41 grams, a reduction of 20.70% compared to the previous year [4] - Water consumption per glove was reduced to 0.21 liters, down 11.02% from the previous year [4] - The company is investing in clean energy, with wind power infrastructure expected to be operational by 2025 [6] Group 3: Social Responsibility and Community Engagement - The company donated over 300 wheelchairs to hospitals and communities, contributing to the equitable distribution of medical resources [8][10] - It has committed over 75.82 million yuan to social welfare since implementing its corporate social responsibility initiatives [10] - The company supports employee development with a 100% training coverage rate and an annual investment of 1.4914 million yuan in skills enhancement [8] Group 4: Corporate Governance and Supply Chain Management - The company has optimized its governance structure, with all seven board members possessing extensive industry knowledge [12] - It is building a sustainable supply chain ecosystem through strict supplier evaluation standards and capacity-building initiatives [12][15] - The company aims to reduce carbon emissions per glove by 25% by 2030 and achieve carbon neutrality in its operations by 2025 [15]

作为全球一次性手套行业的领军企业，英科医疗始终将可持续发展视为企业基因。近日，英科医疗（股 票代码：300677）连续第四年发布《2024年度环境、社会和公司治理（ESG）报告》（以下简称"报 告"），系统性地呈现了其在技术突破、绿色实践、员工关怀及合规治理等维度的深度探索。 ESG 即环境（Environment）、社会（Social）和公司治理（Governance），ESG报告也被称为上市公司 的"第二财报"，是衡量企业社会责任及驱动长期价值增长的关键要素。 报告显示，英科医疗在ESG实践中成果卓著，荣获"A 股医疗器械上市公司ESG TOP20""2024年度上市 公司ESG价值传递奖""金羚奖2024年度ESG创新领军企业"等荣誉；在ESG评级与认证方面，WIND授予 其A级评级，MSCI ESG评定其为BBB级。另外，公司还成功斩获2024年度EcoVadis"COMMITTED"徽 章，进一步提升了行业影响力与公信力。 | MICO | | | | | | --- | --- | --- | --- | --- | | 2024, 可持续发展足迹 | | | | | | 环境E | | | | ...